![image001.png](/uploads/image001_914eca0c1d.png)


## **Save the Date**

COST Action CA21154 – Translational Control in Cancer European Network - TRANSLACORE is pleased to announce the Annual TRANSLACORE Meeting, including the Management Committee (MC) Meeting, to be held in Bologna, Italy, on May 4–5, 2026.


The Final Meeting is a crucial moment for our community to meet in person, wrap up the main objectives of the Action, and strengthen the TRANSLACORE network as we continue addressing our shared scientific goals in translational control and cancer.


**Dates, venue, and format**


**Dates: May 4–5, 2026**
- Venue: [Aula G. Prodi, Piazza San Giovanni in Monte 2, 40124 Bologna, Italy](https://www.google.com/maps/place/Piazza+S.+Giovanni+in+Monte,+2,+40124+Bologna+BO,+W%C5%82ochy/@44.4906947,11.3468975,19z/data=!3m1!4b1!4m6!3m5!1s0x477fd4b8ac0726bf:0x165e1f2f11956782!8m2!3d44.4906937!4d11.3481152!16s%2Fg%2F11pw19tdyc?authuser=0&entry=ttu&g_ep=EgoyMDI2MDIwNC4wIKXMDSoASAFQAw%3D%3D)


**Scientific program highlights**
These two days will be dedicated to science: 
- Plenary scientific sessions with 15–20 min talks
- Keynote lectures
- A short session on the future of TRANSLACORE, focused on legacy, continuity, and next steps beyond the Action


**Hosts**
The meeting will be hosted by **Prof. Marianna Penzo** and **Dr. Erik Dassi**.



We are delighted to invite you to the Management Committee and Working Group Meeting organized under the framework of COST Action CA21154: Translational Control in Cancer European Network - TRANSLACORE. Dates: May 4–5, 2026; Location: Bologna, Italy. 

Face to face Management Committee and Working Groups meeting in Bologna

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

Face to face Management Committee and Working Groups meeting in Bologna